Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the price of this innovative drug and its availability have become key concerns for patients and healthcare practitioners. While tirzepatide has been cleared by regulatory agencies, its expensive nature presents a significant challenge